APO Research
Talk to an analyst

APO RESEARCH · REPORT

Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Growth and Trends Forecast to 2032

27 December 2025109 pages

Choose your research edition.

Industry ResearchParoxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs include Chugai Pharmaceutical, Regeneron Pharmaceuticals, Novartis, Roche, Amgen, Omeros Corporation, NovelMed, AstraZeneca and Apellis Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs market size, estimates, and forecasts are presented in terms of sales volume (Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market by Company

Chugai Pharmaceutical

Regeneron Pharmaceuticals

Novartis

Roche

Amgen

Omeros Corporation

NovelMed

AstraZeneca

Apellis Pharmaceuticals

Alexion

Akari Therapeutics

Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Segment by Type

Oral Drugs

Injectable Drugs

Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Segment by Application

Pharmaceutical and Biotechnology Companies

Clinical

Others

Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Drugs Table 2. Major Company of Injectable Drugs Table 3. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (Units) Table 5. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2027-2032) & (Units) Table 10. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (Units) Table 15. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (Units) Table 17. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (Units) Table 19. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (Units) Table 21. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (Units) Table 23. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Trends Table 25. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Drivers Table 26. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Opportunities and Challenges Table 27. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Restraints Table 28. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Company (2021-2026) & (Units) Table 31. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Share by Company (2021-2026) Table 32. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Major Company Production Sites and Headquarters Table 35. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Company, Product Type & Application Table 36. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region (2021-2026) & (Units) Table 41. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region (2027-2032) & (Units) Table 46. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (Units) Table 52. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2027-2032) & (Units) Table 57. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (Units) Table 62. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (Units) Table 64. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (Units) Table 66. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (Units) Table 68. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (Units) Table 70. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Chugai Pharmaceutical Company Information Table 72. Chugai Pharmaceutical Business Overview Table 73. Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 75. Chugai Pharmaceutical Recent Development Table 76. Regeneron Pharmaceuticals Company Information Table 77. Regeneron Pharmaceuticals Business Overview Table 78. Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 80. Regeneron Pharmaceuticals Recent Development Table 81. Novartis Company Information Table 82. Novartis Business Overview Table 83. Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 85. Novartis Recent Development Table 86. Roche Company Information Table 87. Roche Business Overview Table 88. Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 90. Roche Recent Development Table 91. Amgen Company Information Table 92. Amgen Business Overview Table 93. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 95. Amgen Recent Development Table 96. Omeros Corporation Company Information Table 97. Omeros Corporation Business Overview Table 98. Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 100. Omeros Corporation Recent Development Table 101. NovelMed Company Information Table 102. NovelMed Business Overview Table 103. NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 105. NovelMed Recent Development Table 106. AstraZeneca Company Information Table 107. AstraZeneca Business Overview Table 108. AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 110. AstraZeneca Recent Development Table 111. Apellis Pharmaceuticals Company Information Table 112. Apellis Pharmaceuticals Business Overview Table 113. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 115. Apellis Pharmaceuticals Recent Development Table 116. Alexion Company Information Table 117. Alexion Business Overview Table 118. Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 120. Alexion Recent Development Table 121. Akari Therapeutics Company Information Table 122. Akari Therapeutics Business Overview Table 123. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio Table 125. Akari Therapeutics Recent Development Table 126. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 127. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026) & (Units) Table 128. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country (2021-2026) Table 129. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032) & (Units) Table 130. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share Forecast by Country (2027-2032) Table 131. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 133. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country (2021-2026) Table 134. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share Forecast by Country (2027-2032) Table 136. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 137. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026) & (Units) Table 138. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country (2021-2026) Table 139. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032) & (Units) Table 140. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share Forecast by Country (2027-2032) Table 141. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 143. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country (2021-2026) Table 144. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026) & (Units) Table 148. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country (2021-2026) Table 149. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032) & (Units) Table 150. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 153. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country (2021-2026) Table 154. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share Forecast by Country (2027-2032) Table 156. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 157. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026) & (Units) Table 158. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country (2021-2026) Table 159. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032) & (Units) Table 160. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share Forecast by Country (2027-2032) Table 161. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 163. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country (2021-2026) Table 164. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (Units): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026) & (Units) Table 168. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share by Country (2021-2026) Table 169. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032) & (Units) Table 170. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026) & (US$ Million) Table 173. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country (2021-2026) Table 174. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share Forecast by Country (2027-2032) Table 176. Key Raw Materials Table 177. Raw Materials Key Suppliers Table 178. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Distributors List Table 179. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Customers List Table 180. Research Programs/Design for This Report Table 181. Authors List of This Report Table 182. Secondary Sources Table 183. Primary Sources List of Figures Figure 1. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Image Figure 2. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (2021-2032) & (Units) Figure 5. Oral Drugs Image Figure 6. Global Oral Drugs Sales YoY Growth (2021-2032) & (Units) Figure 7. Injectable Drugs Image Figure 8. Global Injectable Drugs Sales YoY Growth (2021-2032) & (Units) Figure 9. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Pharmaceutical and Biotechnology Companies Image Figure 24. Global Pharmaceutical and Biotechnology Companies Sales YoY Growth (2021-2032) & (Units) Figure 25. Clinical Image Figure 26. Global Clinical Sales YoY Growth (2021-2032) & (Units) Figure 27. Others Image Figure 28. Global Others Sales YoY Growth (2021-2032) & (Units) Figure 29. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 42. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 46. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 50. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 54. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Figure 58. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Oral Drugs
  • Injectable Drugs
Applications
  • Pharmaceutical and Biotechnology Companies
  • Clinical
  • Others
Companies covered
  • Chugai Pharmaceutical
  • Regeneron Pharmaceuticals
  • Novartis
  • Roche
  • Amgen
  • Omeros Corporation
  • NovelMed
  • AstraZeneca
  • Apellis Pharmaceuticals
  • Alexion
  • Akari Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market by Type
  6. 1.3.1 Oral Drugs
  7. 1.3.2 Injectable Drugs
  8. 1.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Type
  9. 1.4.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Trends
  2. 2.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Drivers
  3. 2.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Opportunities and Challenges
  4. 2.4 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Price (2021-2026)
  4. 3.4 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Company, Product Type & Application
  7. 3.7 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Tier 1, Tier 2, and Tier 3
4 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Regional Status and Outlook
  1. 4.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Historic Market Size by Region
  3. 4.2.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs by Application
  1. 5.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market by Application
  2. 5.1.1 Pharmaceutical and Biotechnology Companies
  3. 5.1.2 Clinical
  4. 5.1.3 Others
  5. 5.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Application
  6. 5.2.1 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Chugai Pharmaceutical
  2. 6.1.1 Chugai Pharmaceutical Company Information
  3. 6.1.2 Chugai Pharmaceutical Business Overview
  4. 6.1.3 Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Chugai Pharmaceutical Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  6. 6.1.5 Chugai Pharmaceutical Recent Developments
  7. 6.2 Regeneron Pharmaceuticals
  8. 6.2.1 Regeneron Pharmaceuticals Company Information
  9. 6.2.2 Regeneron Pharmaceuticals Business Overview
  10. 6.2.3 Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Regeneron Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  12. 6.2.5 Regeneron Pharmaceuticals Recent Developments
  13. 6.3 Novartis
  14. 6.3.1 Novartis Company Information
  15. 6.3.2 Novartis Business Overview
  16. 6.3.3 Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Novartis Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  18. 6.3.5 Novartis Recent Developments
  19. 6.4 Roche
  20. 6.4.1 Roche Company Information
  21. 6.4.2 Roche Business Overview
  22. 6.4.3 Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Roche Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  24. 6.4.5 Roche Recent Developments
  25. 6.5 Amgen
  26. 6.5.1 Amgen Company Information
  27. 6.5.2 Amgen Business Overview
  28. 6.5.3 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Amgen Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  30. 6.5.5 Amgen Recent Developments
  31. 6.6 Omeros Corporation
  32. 6.6.1 Omeros Corporation Company Information
  33. 6.6.2 Omeros Corporation Business Overview
  34. 6.6.3 Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Omeros Corporation Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  36. 6.6.5 Omeros Corporation Recent Developments
  37. 6.7 NovelMed
  38. 6.7.1 NovelMed Company Information
  39. 6.7.2 NovelMed Business Overview
  40. 6.7.3 NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 NovelMed Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  42. 6.7.5 NovelMed Recent Developments
  43. 6.8 AstraZeneca
  44. 6.8.1 AstraZeneca Company Information
  45. 6.8.2 AstraZeneca Business Overview
  46. 6.8.3 AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 AstraZeneca Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  48. 6.8.5 AstraZeneca Recent Developments
  49. 6.9 Apellis Pharmaceuticals
  50. 6.9.1 Apellis Pharmaceuticals Company Information
  51. 6.9.2 Apellis Pharmaceuticals Business Overview
  52. 6.9.3 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Apellis Pharmaceuticals Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  54. 6.9.5 Apellis Pharmaceuticals Recent Developments
  55. 6.10 Alexion
  56. 6.10.1 Alexion Company Information
  57. 6.10.2 Alexion Business Overview
  58. 6.10.3 Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Alexion Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  60. 6.10.5 Alexion Recent Developments
  61. 6.11 Akari Therapeutics
  62. 6.11.1 Akari Therapeutics Company Information
  63. 6.11.2 Akari Therapeutics Business Overview
  64. 6.11.3 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Akari Therapeutics Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Product Portfolio
  66. 6.11.5 Akari Therapeutics Recent Developments
7 North America by Country
  1. 7.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
  2. 7.1.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country
  6. 7.2.1 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
  2. 8.1.1 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country
  6. 8.2.1 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
  2. 10.1.1 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country
  6. 10.2.1 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Value Chain Analysis
  2. 12.1.1 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Production Mode & Process
  7. 12.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Distributors
  10. 12.2.3 Paroxysmal Nocturnal Hemoglobinuria (PNH) Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst